⭐️ Update on longer outcomes with ribociclib (Kisqali) and abemaciclib (Verzenio) in hormone receptor positive/HER2 negative early stage breast cancer. ⭐️ These are CDK 4/6 inhibitors given in conjunction with endocrine therapy to reduce risk of recurrence. (CDK 4/6 inhibitors are standard of care in the treatment HR metastatic breast cancer as well). In early stage BC, abemaciclib is taken for 2 years and ribociclib for 3 years. In this video, I share with you recent updates (they are positive!
4:04
FacebookEleonora Teplinsky, MD
⭐️ Update on longer outcomes with ribociclib (Kisqali) and abemaciclib (Verzenio) in hormone receptor positive/HER2 negative early stage breast cancer. ⭐️ These are CDK 4/6
Eleonora Teplinsky, MD. . ⭐️ Update on longer outcomes with ribociclib (Kisqali) and abemaciclib (Verzenio) in hormone receptor positive/HER2 negative early stage breast cancer. ⭐️ These are CDK 4/6 inhibitors given in conjunction with endocrine therapy to reduce risk of recurrence. (CDK 4/6 inhibitors are standard of care in the ...
20.5K views7 months ago
Related Products
Abemaciclib Capsules
Abemaciclib Awareness Ribbon
Abemaciclib 150 Mg
#Abemaciclib Side Effects
In this video, I discuss ribociclib and abemaciclib in early stage HR /HER2- breast cancer. Both are CDK 4/6 inhibitors which interfere with the cell cycle and are used in combination with endocrine therapy to decrease the risk of recurrence. Ribociclib: 400 mg daily 21 days on/7 days off for 3 years At 5 years: absolute improvement in invasive disease free survival (survival without disease) was 4.5% in patients receiving ribociclib (81% in endocrine therapy alone versus 85.5% in ribociclib end
In this video, I discuss ribociclib and abemaciclib in early stage HR /HER2- breast cancer. Both are CDK 4/6 inhibitors which interfere with the cell cycle and are used in combination with endocrine therapy to decrease the risk of recurrence. Ribociclib: 400 mg daily 21 days on/7 days off for 3 years At 5 years: absolute improvement in invasive disease free survival (survival without disease) was 4.5% in patients receiving ribociclib (81% in endocrine therapy alone versus 85.5% in ribociclib end
Facebook5 months ago
Verzenio (abemaciclib): Uses, How It Works, and Common Side Effects
Verzenio (abemaciclib): Uses, How It Works, and Common Side Effects
YouTube9 months ago
Top videos
Differentiating Factors of Abemaciclib Among the CDK 4/6 Inhibitors for Breast Cancer
2:24
Differentiating Factors of Abemaciclib Among the CDK 4/6 Inhibitors for Breast Cancer
YouTubeTargeted Oncology
1.1K viewsMay 30, 2017
Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials)
5:34
Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials)
YouTubeOncologyTube
1.1K views10 months ago
Understanding Abemaciclib: A New CDK4/6 Inhibitor
2:27
Understanding Abemaciclib: A New CDK4/6 Inhibitor
YouTubeOncLive
3.7K viewsDec 1, 2017
Abemaciclib for Breast Cancer
Abemaciclib Delivers New Overall Survival Data in Early Breast Cancer Patients
Abemaciclib Delivers New Overall Survival Data in Early Breast Cancer Patients
medicaldialogues.in
4 months ago
Seven-Year Outcomes From the monarchE Trial: Long-Term Efficacy and Safety of Abemaciclib in Early Breast Cancer | Pharmacy Times
Seven-Year Outcomes From the monarchE Trial: Long-Term Efficacy and Safety of Abemaciclib in Early Breast Cancer | Pharmacy Times
pharmacytimes.com
1 month ago
Aderenza e tollerabilità di abemaciclib nell'early BC HR+/HER2 nel real world - OncoInfo
Aderenza e tollerabilità di abemaciclib nell'early BC HR+/HER2 nel real world - OncoInfo
oncoinfo.it
1 week ago
Differentiating Factors of Abemaciclib Among the CDK 4/6 Inhibitors for Breast Cancer
2:24
Differentiating Factors of Abemaciclib Among the CDK 4/6 Inhibitors for Breast Cancer
1.1K viewsMay 30, 2017
YouTubeTargeted Oncology
Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials)
5:34
Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials)
1.1K views10 months ago
YouTubeOncologyTube
Understanding Abemaciclib: A New CDK4/6 Inhibitor
2:27
Understanding Abemaciclib: A New CDK4/6 Inhibitor
3.7K viewsDec 1, 2017
YouTubeOncLive
Abemaciclib Delivers New Overall Survival Data in Early Breast Cancer Patients
Abemaciclib Delivers New Overall Survival Data in Early Breast Cancer Patients
4 months ago
medicaldialogues.in
Seven-Year Outcomes From the monarchE Trial: Long-Term Efficacy and Safety of Abemaciclib in Early Breast Cancer | Pharmacy Times
Seven-Year Outcomes From the monarchE Trial: Long-Term Efficacy and Safety of Abemaciclib in Early Breast Cancer | Pharmacy Times
1 month ago
pharmacytimes.com
New Survival Advantage for Breast Cancer Patients with Abemaciclib
1:07
New Survival Advantage for Breast Cancer Patients with Abemaciclib
179 views4 weeks ago
YouTubeInnovative Oncology News
Abemaciclib Plus Adjuvant Endocrine Therapy in Breast Cancer | OncLive
Abemaciclib Plus Adjuvant Endocrine Therapy in Breast Cancer | OncLive
Jan 23, 2023
onclive.com
2:39
Abemaciclib Uses, Interactions, Mechanism of Action: The Game-Changer in Breast Cancer Treatment
85 viewsMar 28, 2025
YouTubeHealth Review Desk
Differentiating Between Abemaciclib and Ribociclib | OncLive
3 months ago
onclive.com
22:22
Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
3.7K views7 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discu…
Ribociclib vs. Abemaciclib in Adjuvant eBC Setting
773 viewsFeb 28, 2025
vumedi.com
9:08
Breast Cancer Treatment Options 2025: CDK Inhibitors Guide
24.2K viewsMay 14, 2023
YouTubeDr Liz O'Riordan
23:31
Challenging Cases in Breast Cancer with CDK 4/6 Inhibitors – Drs. Sara Tolaney & Adam Brufsky
4.9K views6 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discu…
10:47
Unlocking the Power of Abemaciclib Medication: A Game-Changer in Cancer Treatment
2.6K viewsAug 26, 2023
YouTubeInevid
2:43
Learn about ABEMACICLIB (A kinase inhibitor) used to treat Cancer
32 views5 months ago
YouTubeCLINICALS WITH PHARM VIC
monarchE Study: The Impact of Dose Reductions on Abemaciclib Efficacy in High-Risk eBC
676 viewsSep 26, 2024
vumedi.com
ASCO® 2025 Insights: TRADE Study - Assessing the Tolerability of Abemaciclib Dose Escalation in HR /HER2- eBC
8 months ago
vumedi.com
Omics profiling of CDK4/6 inhibitors reveals functionally important secondary targets of abemaciclib (Conference Presentation)
Mar 14, 2018
spiedigitallibrary.org
6:43
#abemaciclib | Uses, Dosage, Side Effects & Mechanism | Verzenio
3.6K viewsOct 26, 2023
YouTubeHe-InFo
11:42
Should I Take a CDK4/6 Inhibitor for Breast Cancer?
2.5K viewsFeb 6, 2024
YouTubeCancer Treatment Updates
2:28
Expert Discusses Promise of Abemaciclib for Breast Cancer Treatment
599 viewsMay 31, 2017
YouTubeTargeted Oncology
4:45
Abemaciclib Monotherapy’s Role in HR+ Breast Cancer
343 viewsSep 5, 2018
YouTubeOncLive
8:55
Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optima...
184 viewsApr 12, 2024
YouTubeASCO Podcasts
1:10
Verzenio (abemaciclib): Uses, How It Works, and Common Side Effects
1.2K views9 months ago
YouTubeDrugs.com
7:17
Abemaciclib for ER+ mBC
795 viewsSep 29, 2017
YouTubeOncLive
1:12
monarchE: adjuvant abemaciclib in HR+ breast cancer
868 viewsMar 22, 2021
YouTubeVJOncology
0:53
Hiya everyone just another update on where im at with treatment 🤔🫣 hope your all good xx #abemaciclib #breastcancerawareness💕 #macmillan
1.6K viewsAug 10, 2023
TikToklisaniven123
1:48
NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- breast cancer
755 viewsMay 20, 2024
YouTubeVJOncology
4:52
Choosing an Adjuvant CDK4/6 Inhibitor: Insights From NATALEE and monarchE
1.3K views4 months ago
YouTubeOncUpdates: Latest Oncology Insights
See more
Static thumbnail place holder